Testing effectiveness (Phase 2)Study completedNCT02212379
What this trial is testing
Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL
Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 170